30 results on '"van Lunzen, Jan"'
Search Results
2. Patient-Reported Symptoms over 48 Weeks in a Randomized, Open-Label, Phase 3b Non-inferiority Trial of Adults with HIV Switching to Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir DF Versus Continuation of Ritonavir-Boosted Protease Inhibitor with Emtricitabine and Tenofovir DF
3. Low SAMHD1 expression following T-cell activation and proliferation renders CD4+ T cells susceptible to HIV-1
4. Reduced expression of Blimp-1 in memory B cells in patients with HIV-1 infection suggests distinct roles of this molecule for B and T cell regulation
5. Week 48 results from a randomized clinical trial of rilpivirine/emtricitabine/tenofovir disoproxil fumarate vs. efavirenz/emtricitabine/tenofovir disoproxil fumarate in treatment-naive HIV-1-infected adults
6. Simplification to rilpivirine/emtricitabine/tenofovir disoproxil fumarate from ritonavir-boosted protease inhibitor antiretroviral therapy in a randomized trial of HIV-1 RNA-suppressed participants
7. Expansion of HIV-specific T follicular helper cells in chronic HIV infection
8. Background morbidity in HIV vaccine trial participants from various geographic regions as assessed by unsolicited adverse events
9. Treatment of AIDS-related lymphomas: rituximab is beneficial even in severely immunosuppressed patients
10. IL-10 induces aberrant deletion of dendritic cells by natural killer cells in the context of HIV infection
11. Epidemiologically linked transmission of HIV-1 illustrates the impact of host genetics on virological outcome
12. Does less frequent routine monitoring of patients on a stable, fully suppressed cART regimen lead to an increased risk of treatment failure?
13. Primary HIV infection presenting as haemolytic crisis in a patient with previously undiagnosed glucose 6-phosphate dehydrogenase deficiency
14. Efficacy and safety of once-daily darunavir/ritonavir versus lopinavir/ritonavir in treatment-naive HIV-1-infected patients at week 48
15. Impact of CYP2B6 983T>C polymorphism on non-nucleoside reverse transcriptase inhibitor plasma concentrations in HIV-infected patients
16. Adoptive transfer of syngeneic T cells in HIV-1 discordant twins indicates rapid regulation of T-cell homeostasis
17. Decline in Esophageal Candidiasis and Use of Antimycotics in European Patients with HIV
18. Strong impact of highly active antiretroviral therapy on survival in patients with human immunodeficiency virus-associated Hodgkinʼs disease
19. Delayed central nervous system virus suppression during highly active antiretroviral therapy is associated with HIV encephalopathy, but not with viral drug resistance or poor central nervous system drug penetration
20. Effects of interleukin-2 plus highly active antiretroviral therapy on HIV-1 replication and proviral DNA (COSMIC trial)
21. Expansion of pre-existing, lymph node-localized CD8+ T cells during supervised treatment interruptions in chronic HIV-1 infection
22. The use of and response to second-line protease inhibitor regimens: results from the EuroSIDA study
23. Predictors of Virological Success and Ensuing Failure in HIV-Positive Patients Starting Highly Active Antiretroviral Therapy in Europe: Results From the EuroSIDA Study
24. Measuring Recent Thymic Emigrants in Blood of Normal and HIV-1-infected Individuals before and after Effective Therapy
25. Relations among CD4 Lymphocyte Count Nadir, Antiretroviral Therapy, and HIV-1 Disease Progression: Results from the EuroSIDA Study
26. Protease inhibitor-containing regimens compared with nucleoside analogues alone in the suppression of persistent HIV-1 replication in lymphoid tissue
27. The Unenlarged Lymph Nodes of HIV-1-infected, Asymptomatic Patients with High CD4 T Cell Counts Are Sites for Virus Replication and CD4 T Cell Proliferation. The Impact of Highly Active Antiretroviral Therapy
28. Asymptomatic HIV infection is characterized by rapid turnover of HIV RNA in plasma and lymph nodes but not of latently infected lymph-node CD4+ T cells
29. Germinal centre CD4+ T cells are an important site of HIV replication in vivo
30. Rapid plasma virus and CD4+T-cell turnover in HIV-1 infection: evidence for an only transient interruption by treatment
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.